Vincent Gerusz
Debiopharm (Switzerland)(CH)
Publications by Year
Research Areas
Antibiotic Resistance in Bacteria, Bacterial Genetics and Biotechnology, Antimicrobial Resistance in Staphylococcus, Carbohydrate Chemistry and Synthesis, Bacteriophages and microbial interactions
Most-Cited Works
- → Discovery of new Gram-negative antivirulence drugs: Structure and properties of novel E. coli WaaC inhibitors(2008)90 cited
- → The MUT056399 Inhibitor of FabI Is a New Antistaphylococcal Compound(2011)73 cited
- → Towards Gram-negative antivirulence drugs: New inhibitors of HldE kinase(2008)72 cited
- → From Triclosan toward the Clinic: Discovery of Nonbiocidal, Potent FabI Inhibitors for the Treatment of Resistant Bacteria(2012)54 cited
- → Systematic Synthesis of Inhibitors of the Two First Enzymes of the Bacterial Heptose Biosynthetic Pathway: Towards Antivirulence Molecules Targeting Lipopolysaccharide Biosynthesis(2011)46 cited
- → Novel HldE-K Inhibitors Leading to Attenuated Gram Negative Bacterial Virulence(2013)32 cited
- → Recent Advances in the Inhibition of Bacterial Fatty Acid Biosynthesis(2010)29 cited
- → Structural–Functional Studies of Burkholderia cenocepacia d-Glycero-β-d-manno-heptose 7-Phosphate Kinase (HldA) and Characterization of Inhibitors with Antibiotic Adjuvant and Antivirulence Properties(2012)18 cited
- → Towards Gram-positive antivirulence drugs: New inhibitors of Streptococcus agalactiae Stk1(2010)5 cited
- → Vectorization Efforts To Increase Gram-Negative Intracellular Drug Concentration: A Case Study on HldE-K Inhibitors(2013)4 cited